New Light on the Brain: The Role of Photosensitizing Agents and Laser Light in the Management of Invasive Intracranial Tumors

Invasive intracranial tumors, particularly malignant gliomas, are very difficult to eradicate surgically and carry a dismal prognosis. The vast majority relapse locally indicating that their cure is dependent on radical and complete local excision. However, their ability to invade and hide among normal brain tissue, our inability to visualize and detect them, the low tolerance of brain tissue to ionizing radiation and the presence of the blood brain barrier are the main causes of our failure to eradicate them. Photodynamic detection with 100% specificity and more than 80% sensitivity offers an excellent chance of visualizing camouflaged tumor nests. Also, photodynamic therapy offers a very good chance of targeted destruction of the remaining tumor cells safely following surgical excision and may double the survival of patients harboring these awful tumors. More work needs to be done to refine this promising technology to exploit it to its full potential.

[1]  H Stepp,et al.  Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. , 1998, Neurosurgery.

[2]  A H Kaye,et al.  Photodynamic therapy of brain tumors. , 1996, Seminars in surgical oncology.

[3]  J. Shinoda,et al.  [Experimental study of photoradiation therapy by argon-pumped dye laser and hematoporphyrin derivative on malignant brain tumor model]. , 1986, Neurologia medico-chirurgica.

[4]  A. Kaye,et al.  Selective tumor kill of cerebral glioma by photodynamic therapy using a boronated porphyrin photosensitizer. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[5]  N. Bleehen,et al.  Radiotherapy, hyperthermia, and photodynamic therapy for central nervous system tumors. , 1993, Current Opinion in Oncology.

[6]  W. Stummer,et al.  Experimental Research Photodynamic Effects in Perifocal, Oedematous Brain Tissue , 2002, Acta Neurochirurgica.

[7]  B. Wilson,et al.  PHOTODYNAMIC THERAPY OF MALIGNANT PRIMARY BRAIN TUMOURS: CLINICAL EFFECTS, POSTOPERATIVE ICP, and LIGHT PENETRATION OF THE BRAIN , 1987, Photochemistry and photobiology.

[8]  R. Martuza,et al.  Cytotoxicity of human brain tumors by hematoporphyrin derivative. , 1986, Journal of Surgical Research.

[9]  L. Lilge,et al.  Photodynamic therapy of intracranial tissues: a preclinical comparative study of four different photosensitizers. , 1998, Journal of clinical laser medicine & surgery.

[10]  J E Moulder,et al.  The role of photodynamic therapy in posterior fossa brain tumors. A preclinical study in a canine glioma model. , 1993, Journal of neurosurgery.

[11]  A. Kaye,et al.  A review of photoradiation therapy in the management of central nervous system tumours. , 1988, The Australian and New Zealand journal of surgery.

[12]  D. Hau,et al.  Therapeutic effects of photosensitizers in combination with laser and ACNU on an in vivo or in vitro model of cerebral glioma. , 1995, Chinese Medical Journal.

[13]  S. K. Powers,et al.  IMPROVED SURVIVAL FROM INTRACAVITARY PHOTODYNAMIC THERAPY OF RAT GLIOMA , 1992, Photochemistry and photobiology.

[14]  J. Frisoli,et al.  Pharmacokinetics of a fluorescent drug using laser-induced fluorescence. , 1993, Cancer research.

[15]  Bernhard Olzowy,et al.  Photoirradiation therapy of experimental malignant glioma with 5-aminolevulinic acid. , 2002, Journal of neurosurgery.

[16]  Photoradiation therapy of 9L-gliosarcoma in rats: hematoporphyrin derivative (types I and II) followed by laser energy , 2004, Journal of Neuro-Oncology.

[17]  S. Stylli,et al.  Selective tumor uptake of a boronated porphyrin in an animal model of cerebral glioma. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[18]  S. Thomson,et al.  Effect of photodynamic therapy on recurrent pituitary adenomas: clinical phase I/II trial ‘ an early report , 2000, British journal of neurosurgery.

[19]  C Rivano,et al.  Fast attempts at the photodynamic treatment of human gliomas. , 1980, Journal of neurosurgical sciences.

[20]  M. Kao,et al.  Comparative study on the ALA photodynamic effects of human glioma and meningioma cells , 1999, Lasers in surgery and medicine.

[21]  W. Stummer,et al.  Technical Principles for Protoporphyrin-IX-Fluorescence Guided Microsurgical Resection of Malignant Glioma Tissue , 1998, Acta Neurochirurgica.

[22]  A. Obwegeser,et al.  Therapy of glioblastoma multiforme: A cumulative experience of 10 years , 2005, Acta Neurochirurgica.

[23]  R. R. Smith,et al.  The long-term side effects of radiation therapy for benign brain tumors in adults. , 1990, Journal of neurosurgery.

[24]  A H Kaye,et al.  Selective uptake of hematoporphyrin derivative into human cerebral glioma. , 1990, Neurosurgery.

[25]  B. Wilson,et al.  Photo-Dynamic Therapy: Cavitary Photo-Illumination of Malignant Cerebral Tumours Using a Laser Coupled Inflatable Balloon , 1985, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[26]  P. Kornblith The role of cytotoxic chemotherapy in the treatment of malignant brain tumors. , 1995, Surgical Neurology.

[27]  Henry Hirschberg,et al.  Effects of Combined Photodynamic Therapy and Ionizing Radiationon Human Glioma Spheroids¶ , 2002, Photochemistry and photobiology.

[28]  M Chopp,et al.  Photodynamic Therapy of Human Glioma (U87) in the Nude Rat , 1996, Photochemistry and photobiology.

[29]  W. Stummer,et al.  Kinetics of Photofrin II in perifocal brain edema. , 1993, Neurosurgery.

[30]  R. Bjerkvig,et al.  Effects of photodynamic therapy on glioma spheroids. , 1997, British journal of neurosurgery.

[31]  K. Uemura,et al.  Photodynamic therapy using pheophorbide a and Nd:YAG laser. , 1991, Neurologia medico-chirurgica.

[32]  H. Kostron,et al.  Photodynamic therapy of malignant brain tumours: a phase I/II trial. , 1988, British journal of neurosurgery.

[33]  H. Abe,et al.  [Photoradiation therapy of experimental glioma]. , 1985, Neurologia medico-chirurgica.

[34]  N. Joshi,et al.  Ca2+ INFLUX INDUCED BY PHOTODYNAMIC ACTION IN HUMAN CEREBRAL GLIOMA (U‐87 MG) CELLS: POSSIBLE INVOLVEMENT OF A CALCIUM CHANNEL , 1994, Photochemistry and photobiology.

[35]  L. D.,et al.  Brain tumors , 2005, Psychiatric Quarterly.

[36]  P Muller,et al.  Photodynamic therapy of brain tumours--post-operative "field fractionation". , 1991, Journal of photochemistry and photobiology. B, Biology.

[37]  A H Kaye,et al.  Adjuvant high-dose photoradiation therapy in the treatment of cerebral glioma: a phase 1-2 study. , 1987, Journal of neurosurgery.

[38]  H. Laborit,et al.  [Experimental study]. , 1958, Bulletin mensuel - Societe de medecine militaire francaise.

[39]  Y Lajat,et al.  Effects of photodynamic therapy on adhesion molecules and metastasis. , 1999, Journal of photochemistry and photobiology. B, Biology.

[40]  Satish Krishnamurthy,et al.  Optimal light dose for interstitial photodynamic therapy in treatment for malignant brain tumors , 2000 .

[41]  B. Wilson,et al.  Instrumentation and light dosimetry for intra-operative photodynamic therapy (PDT) of malignant brain tumours. , 1986, Physics in medicine and biology.

[42]  T. Origitano,et al.  Photodynamic therapy for intracranial neoplasms: development of an image-based computer-assisted protocol for photodynamic therapy of intracranial neoplasms. , 1993, Neurosurgery.

[43]  L. Kwock,et al.  Stereotactic intratumoral photodynamic therapy for recurrent malignant brain tumors. , 1991, Neurosurgery.

[44]  M. Mahaley Neuro-oncology index and review (adult primary brain tumors) , 1991, Journal of neuro-oncology.

[45]  J. Moan,et al.  Tumor-localizing and photosensitizing properties of the main components of hematoporphyrin derivative. , 1984, Cancer research.

[46]  B. Scheithauer,et al.  Results of surgical treatment for growth hormone-secreting pituitary adenomas. , 1993, Journal of neurosurgery.

[47]  P. Babinec,et al.  Gene transfer-mediated intracellular photodynamic therapy. , 2000, Medical hypotheses.

[48]  J. Boggan,et al.  Effectiveness of a lysyl chlorin p6/chlorin p6 mixture in photodynamic therapy of the subcutaneous 9L glioma in the rat. , 1992, Cancer research.

[49]  Harry T. Whelan,et al.  Preclinical Evaluation of Benzoporphyrin Derivative Combined with a Light-Emitting Diode Array for Photodynamic Therapy of Brain Tumors , 1999, Pediatric Neurosurgery.

[50]  T J Dougherty,et al.  2‐[1‐hexyloxyethyl]‐2‐devinyl pyropheophorbide‐a (HPPH) in a nude rat glioma model: Implications for photodynamic therapy , 2001, Lasers in surgery and medicine.

[51]  S. Gibson,et al.  Chalcogenapyrylium dyes as photochemotherapeutic agents. 2. Tumor uptake, mitochondrial targeting, and singlet-oxygen-induced inhibition of cytochrome c oxidase. , 1990, Journal of medicinal chemistry.

[52]  A H Kaye,et al.  Photodynamic therapy of brain tumors. , 1995, Journal of clinical laser medicine & surgery.

[53]  A. Kaye Photoradiation therapy of brain tumours. , 1989, Ciba Foundation symposium.

[54]  A H Kaye,et al.  Photoradiation therapy and its potential in the management of neurological tumors. , 1988, Journal of neurosurgery.

[55]  W. Stummer,et al.  In vitro and in vivo porphyrin accumulation by C6 glioma cells after exposure to 5-aminolevulinic acid. , 1998, Journal of photochemistry and photobiology. B, Biology.

[56]  M Chopp,et al.  Sensitivity of 9L gliosarcomas to photodynamic therapy. , 1996, Radiation research.

[57]  Henry Hirschberg,et al.  5-Aminolevulinic acid-based photodynamic detection and therapy of brain tumors (review). , 2002, International journal of oncology.

[58]  D. Deen,et al.  The effect of bromodeoxyuridine and ultraviolet light on 9L rat brain tumor cells. , 1989, Radiation Research.

[59]  S. K. Powers,et al.  Interstitial laser photochemotherapy of rhodamine-123-sensitized rat glioma. , 1987, Journal of neurosurgery.

[60]  B. Tromberg,et al.  Development of a novel indwelling balloon applicator for optimizing light delivery in photodynamic therapy , 2001, Lasers in surgery and medicine.

[61]  L. Lilge,et al.  Photodynamic Therapy of 9L Gliosarcoma with Liposome‐Delivered Photofrin , 1997, Photochemistry and photobiology.

[62]  W. Kamphorst,et al.  Damage to Tumour and Brain by Interstitial Photodynamic Therapy in the 9L Rat Tumour Model Comparing Intravenous and Intratumoral Administration of the Photosensitiser , 1998, Acta Neurochirurgica.

[63]  T J Dougherty,et al.  PHOTOSENSITIZERS: THERAPY AND DETECTION OF MALIGNANT TUMORS , 1987, Photochemistry and photobiology.

[64]  F. Halberg,et al.  Radiotherapy of pituitary tumors. , 1987, Endocrinology and metabolism clinics of North America.

[65]  A. Obwegeser,et al.  Uptake and kinetics of 14C-labelled meta-tetrahydroxyphenylchlorin and 5-aminolaevulinic acid in the C6 rat glioma model. , 1998, British Journal of Cancer.

[66]  S. Matsumoto,et al.  Photodynamic therapy of experimental 9L gliosarcoma--cytocidal effect and pathohistological analysis. , 1987, Neurologia medico-chirurgica.

[67]  B. Wilson,et al.  Photodynamic therapy for recurrent supratentorial gliomas. , 1995, Seminars in surgical oncology.

[68]  Y Lajat,et al.  Heterogeneity of 6-aminolevulinic acid-induced protoporphyrin IX fluorescence in human glioma cells and leukemic lymphocytes , 2000, Neurological research.

[69]  W. Stummer,et al.  Photodynamic therapy within edematous brain tissue: considerations on sensitizer dose and time point of laser irradiation. , 1996, Journal of photochemistry and photobiology. B, Biology.

[70]  Y Lajat,et al.  Photochemotherapy applied stereotactically to brain tumors. , 1987, Surgical neurology.

[71]  Kevin M. Smith,et al.  In vitro PHOTODYNAMIC EFFECTS OF LYSYL CHLORIN p6: CELL SURVIVAL, LOCALIZATION AND ULTRASTRUCTURAL CHANGES , 1993, Photochemistry and photobiology.

[72]  R. Wharen,et al.  Hematoporphyrin derivative photocytotoxicity of human glioblastoma in cell culture. , 1986, Neurosurgery.

[73]  M. Berns,et al.  Hematoporphyrin derivative photoradiation therapy of the rat 9L gliosarcoma brain tumor model , 1984, Lasers in surgery and medicine.

[74]  S. Stylli,et al.  Evaluation of porphyrin C analogues for photodynamic therapy of cerebral glioma. , 1996, British Journal of Cancer.

[75]  P. Marks Photodynamic therapy for central nervous system tumours: achievements and prospects. , 1999, British journal of neurosurgery.

[76]  A. D. Ward,et al.  Phototherapy in malignant brain tumors. , 1984, Progress in clinical and biological research.

[77]  Walter Stummer,et al.  Kinetics of Photofrin II in perifocal brain edema. , 1993, Neurosurgery.

[78]  A. E. Saarnak,et al.  5-Aminolevulinic Acid Induced Endogenous Porphyrin Fluorescence in 9L and C6 Brain Tumours and in the Normal Rat Brain , 1998, Acta Neurochirurgica.

[79]  Bruce J. Tromberg,et al.  ALA- and ALA-ester-mediated Photodynamic Therapy of Human Glioma Spheroids , 2002, Journal of Neuro-Oncology.

[80]  A H Kaye,et al.  Uptake and retention of hematoporphyrin derivative in an in vivo/in vitro model of cerebral glioma. , 1985, Neurosurgery.

[81]  H Stepp,et al.  Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. , 2000, Journal of neurosurgery.

[82]  S. Leibel,et al.  Radiation therapy for neoplasms of the brain. , 1987, Journal of neurosurgery.

[83]  Phototoxicity of brain tissue in hematoporphyrin derivative treated mice. , 1984, Progress in clinical and biological research.

[84]  Q. Peng,et al.  Uptake, localization, and photodynamic effect of meso-tetra(hydroxyphenyl)porphine and its corresponding chlorin in normal and tumor tissues of mice bearing mammary carcinoma. , 1995, Cancer research.

[85]  A. Girotti,et al.  Singlet oxygen intermediacy in the photodynamic action of membrane-bound hematoporphyrin derivative. , 1987, Cancer letters.

[86]  T. Origitano,et al.  Photodynamic therapy for intracranial neoplasms , 1994, Molecular and chemical neuropathology.

[87]  Y. Yoshii,et al.  Use of Photoactivation by Argon Laser in Treatment of Brain Tumors (Part I) , 1983 .

[88]  Photosensitization of human glioma cells by chalcogenapyrylium dyes , 1989, Journal of Neuro-Oncology.

[89]  B. C. Wilson,et al.  The sensitivity of normal brain and intracranially implanted VX2 tumour to interstitial photodynamic therapy. , 1996, British Journal of Cancer.

[90]  H. Kostron,et al.  PHOTODYNAMIC THERAPY OF MALIGNANT BRAIN TUMORS: CLINICAL and NEUROPATHOLOGICAL RESULTS , 1987, Photochemistry and photobiology.

[91]  T. Mikkelsen,et al.  Tamoxifen Increases Photodynamic Therapeutic Response of U87 and U25ln Human Glioma Cells , 2004, Journal of Neuro-Oncology.

[92]  Douglas C. Miller,et al.  The interaction of hematoporphyrin derivative, light, and ionizing radiation in a rat glioma model , 1986, Cancer.

[93]  T. Goodell,et al.  Photodynamic Therapy: A Novel Treatment for Primary Brain Malignancy , 2001, The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses.

[94]  Selective necrosis of malignant gliomas in mice using photodynamic therapy. , 1987, British Journal of Cancer.

[95]  A H Kaye,et al.  Phase I and pharmacokinetic study of photodynamic therapy for high-grade gliomas using a novel boronated porphyrin. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[96]  L. Lilge,et al.  Apoptosis induced in vivo by photodynamic therapy in normal brain and intracranial tumour tissue , 2000, British Journal of Cancer.

[97]  E. Laws,et al.  Activity of phthalocyanine photosensitizers against human glioblastoma in vitro. , 1987, Neurosurgery.

[98]  M. Muruganandham,et al.  Binding of monomeric and oligomeric porphyrins to human glioblastoma (U-87MG) cells and their photosensitivity. , 1997, Cancer letters.